SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-128864
Filing Date
2022-12-21
Accepted
2022-12-21 08:00:39
Documents
19
Period of Report
2022-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2232888d2_8k.htm   iXBRL 8-K 48233
2 EXHIBIT 4.1 tm2232888d2_ex4-1.htm EX-4.1 724247
6 GRAPHIC image_001.jpg GRAPHIC 2222
7 GRAPHIC image_002.jpg GRAPHIC 2892
8 GRAPHIC image_003.jpg GRAPHIC 2789
9 GRAPHIC image_004.jpg GRAPHIC 3051
10 GRAPHIC image_005.jpg GRAPHIC 2609
11 GRAPHIC image_006.jpg GRAPHIC 3642
  Complete submission text file 0001104659-22-128864.txt   1118299

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvax-20221220.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20221220_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20221220_pre.xml EX-101.PRE 22593
13 EXTRACTED XBRL INSTANCE DOCUMENT tm2232888d2_8k_htm.xml XML 3479
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 221476576
SIC: 2836 Biological Products, (No Diagnostic Substances)